TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nord Vacc Läkemedel AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
10,921
|
7,359
|
6,451 |
| Financial expenses |
87
|
105
|
12 |
| Earnings before taxes |
-3,384
|
-10,240
|
-750 |
| EBITDA |
-3,286
|
-10,098
|
-1,028 |
| Total assets |
6,233
|
5,100
|
8,563 |
| Current assets |
6,200
|
5,056
|
6,838 |
| Current liabilities |
2,131
|
1,841
|
1,438 |
| Equity capital |
471
|
320
|
565 |
| - share capital |
471
|
471
|
471 |
| Employees (average) |
3
|
2
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
7.6%
|
6.3%
|
6.6% |
| Turnover per employee |
3,640
|
3,680
|
2,150 |
| Profit as a percentage of turnover |
-31.0%
|
-139.1%
|
-11.6% |
| Return on assets (ROA) |
-52.9%
|
-198.7%
|
-8.6% |
| Current ratio |
290.9%
|
274.6%
|
475.5% |
| Return on equity (ROE) |
-718.5%
|
-3200%
|
-132.7% |
| Change turnover |
3,562
|
908
|
1,806 |
| Change turnover % |
48%
|
14%
|
39% |
| Chg. No. of employees |
1
|
-1
|
0 |
| Chg. No. of employees % |
50%
|
-33%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.